Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Brevel Expands Seed Round to US$25 Million Through Warrant Exercise
-
Lightspeed Updates Fiscal 2025 Financial Outlook
-
Herbalife Fuels the Women's College All-Star Game as Official Nutrition and Hydration Sponsor
-
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
-
U Power Limited (Nasdaq: UCAR) Announces Landmark Joint Venture with SUSCO, Targeting Thailand's Multi-Billion EV Infrastructure Boom
-
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
-
OneLayer and Ericsson Unveil Advanced Zero Touch Zero Trust Network Access Solution for Private Cellular Networks
-
Fast Guard Service Ushers in the Future of Security Guard Services Across California
-
TicketOS Named Official Corporate Ticket Management Partner of the Washington Nationals
-
Inclusionism: Finally! A Blueprint for the Bold Transformation of Capitalism -- Co-Written by Two AI Systems in a Historic Partnership
-
Keeper Security Wins Multiple Cybersecurity Excellence Awards, Including Most Innovative Cybersecurity Company
-
Trilogy Real Estate Group Fully Subscribes Luxury Multifamily DST Offering Near Milwaukee
-
Foresight Group Expands Product, Service Portfolio with New Trade Show Solutions and Multi-Format Inserter for Direct Mail
-
U. S. Steel Highlights Proven Track Record and Commitment to Delivering Stockholder Value in Definitive Proxy Statement and Stockholder Letter
-
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
-
Aura Completes Series G Funding Round, Raises $140 Million in Equity and Debt
-
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
-
PitBullTax Software Unveils Version 8.0: The Future of Tax Resolution in an AI-Driven IRS Era
-
Infor and Kinaxis Launch Enterprise Planning Solution for Discrete Manufacturers
-
Oshkosh Defense Unveils ROGUE-Fires with MFOM at AUSA GFS 2025
-
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
-
Meet Cove Architecture, the First AI-Powered Full-Service Architecture Services Firm From cove
-
Veeder-Root Unveils the Red Jacket® IQ2 Smart Controller: Revolutionizing Pump Management
-
Skoll Foundation Announces Winners of the 2025 Skoll Award for Social Innovation
-
Eagle Capital Celebrates One-Year Anniversary of EAGL ETF
-
Missouri American Water Accepts Applications for Hydration Station Grants
-
Essential Utilities Marks Five Years of Strength, Innovation and Growth
-
Transpire Delivers AI-Assisted Story Building with Case Concepts
-
Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.
-
Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail
-
MAG Silver Reports 2024 Annual Financial Results
-
Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value
-
Next Hydrogen Announces Strategic Partnership with Sungrow Hydrogen
-
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
-
Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.
-
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
-
Rapid7 Appoints Three New Board Members
-
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
-
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular
-
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Sin
-
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Transactions in connection with share buyback programme
-
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
-
Power Knot Ocean Delivers LFC Biodigester for MS Seaventure
-
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
-
TISE reports record turnover, profit & EPS for 2024
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025
-
Northern Trust Asset Management Names UK Head of Sales

